Performance History
| Key Stats | |
|---|---|
| Open | $2.48 |
| Prev. Close | $2.50 |
| EPS | -0.77 |
| Dividend | Non-Dividend |
| Next Earnings Date | - |
| Dividend Yield % | - |
| Market Cap | 14572081.00 |
| PE Ratio | - |
| LOW | HIGH | |
|---|---|---|
| Day Range | 2.36 | 2.48 |
| 52 Week Range | 2.06 | 5.15 |
| Ratios | |
|---|---|
| P/B Ratio | 2.40 |
| Revenue | - |
| Operating M. % | -17.37% |
| Earnings | $0.00 |
| Earnings Growth % | -283.21% |
| EBITDA Margin % | -6.34% |
| ROE % | -47.63% |
| EPS | -0.77 |
Score Breakdown
Welcome to Stocklytics
Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.
Financial Forecast
AI Price Prediction
Analyst Ratings
Correlated Companies
About Psychemedics (PMD)
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- CEO
- Mr. Brian Hullinger
- Headquarters
- Acton
- Employees
- 133
- Exchange
- NASDAQ
Keep an eye on Psychemedics
Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.
Frequently Asked Questions
What is Psychemedics's (PMD) price per share?
The current price per share for Psychemedics (PMD) is $2.37. The stock has seen a price change of $0.05 recently, indicating a 2.16% change. This reflects the stock's recent market performance and investor sentiment.
What is the 52-week high and low for Psychemedics (PMD)?
For Psychemedics (PMD), the 52-week high is $5.15, which is 117.3% from the current price. The 52-week low is $2.06, the current price is 15.05% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.
Is Psychemedics (PMD) a growth stock?
Psychemedics (PMD) has shown an average price growth of 0.41% over the past three years. It has received a score of 23 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Psychemedics as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.
What is Psychemedics (PMD) stock price performance year to date (YTD)?
As of the latest data, Psychemedics (PMD) has a year-to-date price change of -30.09%. Over the past month, the stock has experienced a price change of -6.69%. Over the last three months, the change has been -22.3%. Over the past six months, the figure is -25%. Looking at a longer horizon, the five-year price change stands at -75.94%.
Is Psychemedics (PMD) a profitable company?
Psychemedics (PMD) has a net income of -$4.15M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of 38.07% indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of -17.37% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at , although specific revenue growth data is currently not available. The gross profit is $8.41M. Operating income is noted at -$2.92M. Furthermore, the EBITDA is $256K.
What is the market capitalization of Psychemedics (PMD)?
Psychemedics (PMD) has a market capitalization of $14.57M. The average daily trading volume is 8.6K, indicating the stock's liquidity and investor engagement.
News
Nvidia’s Five-Year Stock Return Skyrockets to 2,855%, Twice that of Tesla and 12x Higher than Microsoft’s or Alphabet’s
Lenovo’s Saudi Expansion: A Catalyst for AI-Related Stock Appeal
Global GPU Market Projected to Reach $274 Billion by 2029
Gaming Sector Now Accounts for Approximately One-Tenth of Nvidia’s Revenues
Nvidia Poised for $10 Trillion Valuation by 2030, Driven by Blackwell GPUs and CUDA Software
Smart City Technologies to Become a $100 Billion Industry this Year
Sign up for our newsletter
Join our exclusive community of over one million investment enthusiasts and receive our free newsletter filled with analysis, news, and updates every weekday.